Bioactive Materials Market

Bioactive Materials Market Growth Outlook (2023 to 2033)

The global market for bioactive materials is poised to grow at a rate of 11.3% during the projected period 2023 - 2033. Also, the market is expected to reach a valuation of US$ 8.0 billion by 2033 owing to the increasing use in bioengineering and medical equipment development.

Bioactive materials are becoming the preferred choice of medical practitioners on account of bioactive material's functionality.

Report Attributes	Details
Bioactive Materials Market Size (2022A)	US$ 2.5 Billion
Estimated Market Value (2023E)	US$ 2.8 Billion
Forecasted Market Value (2033F)	US$ 8.0 Billion
Global Market Growth Rate (2023–2033)	11.3% CAGR
North America Market Share (2022)	26.2%
Key Companies Profiled	Zimmer Holding Inc. Medtronic Inc. Stryker Corporation Biomatlante Arthrex, Inc. Bioactive Bone Substitutes Oy C.I. TAKIRON Corporation

Historic to Future Pathway of Bioactive Material Market

Bioactive materials help to restore, improve and maintain tissue functions and provide additional technical features such as antimicrobial properties. Bioengineering is proving to be a very important tool for the improvement of surgical practices. It not only helps to restore the tissues as well as it can be used as a body implant.

Bioactive materials are mostly used for repairing tissue damage in elderly people. Owing to the growing geriatric population across North America and Europe, the demand is expected to rise from these regions.

• Growth Factors for Short Term (2023–2026): With the growing count of surgical practices for tissue regrowth and bone implants the demand for the bioactive materials market is anticipated to increase.
• Factors for Medium-Term Growth (2026–2029): With the advent of technological advancement in healthcare facilities and the prevalence of various bone-related issues in the elderly as well as young population, the consumption of bioactive material is expected to increase.
• Long-Term Growth Opportunities (2029–2033): Market participants have additional plans to invest in bioactive materials research and development in response to rising demand up to the long-term forecast.

According to Fact.MR, the market for bioactive materials has grown at a CAGR of 9.9% from 2018 to 2022 and is expected to grow at a CAGR of 11.3% from 2023 to 2033

Factor’s contributing to the expansion of the Bioactive Materials Market

“Demand across Surgical Procedures to Drive Bioactive Material Market”

In-situ study on bioactive materials has been extensively carried out for the past decade. However, improving technology and advancement in medical science have increased the market valuation of bioactive materials. Owing to properties exhibited by bioactive materials such as osteoconduction that help in bone regrowth from the surface, while osteoinduction helps to differentiate from osteoblastic lineages, escalates its use in dental as well as bone-implants.

Additionally, bioactive materials are inert to fluids & tissues and thus cause no cross-reaction to them. According to the organization, a global observatory on donation and transplantation, around 1,44,302 organs were transplanted in 2021. The increasing number of organ transplantation cases to fuel the demand for bioactive materials in the grafting process. The process of incorporating active ingredients into a surface and further utilizing it for tissue replenishment is often termed bioengineering.

“Factors Restraining the Market Growth of Bioactive Materials”

To guarantee their quality and efficacy, biomaterial-based medical devices are strictly controlled in several areas, including North America and Europe. This is partly because most medical devices made of bioactive materials can be implanted. Before being given the go-ahead for commercialization, any novel bioactive material must demonstrate that it is trustworthy and secure. The FDA has set strict guidelines and restrictions that must be followed during the US clearance procedure.

Heart valves, stents, and implantable pacemakers are a few examples of biomaterial-based products that the FDA has classified as Class III devices, which are those that pose the greatest risk of illness or injury. As a result, these products use the premarket approval application process (the most stringent type of device marketing application). Such factors add additional operational cost and competition threat to the bioactive material market.a

Country-wise Insights

What are the Demand Prospects for the U.S. for Bioactive Materials?

The U.S. continues to be the most attractive location for producers of bioactive materials, with an absolute dollar opportunity of US$ 0.9 Billion. The country’s promising healthcare sector is a major contributor to the bioactive materials market growth.

Modern dentistry clinics in the United States have evolved and employ cutting-edge technology. The market for dental supplies in North America was worth US$ 1.5 billion in 2022. Moreover, the population-to-dentist ratio in the area has gone up. Dentistry is one of the main industries utilizing bioactive materials, and it is predicted that this industry will have enormous opportunities in the years to come across the country.

Why Chinese Market is Highly Preferred by the Bioactive Materials Manufacturers?

The demand for bioactive materials and other cutting-edge dental and oral care products has significantly increased as a result of China's sharp rise in oral care awareness.

Bioactive materials are witnessing a growth rate of 13.5% across China, and healthcare investment and individual spending on oral care are likely to pullulate the bioactive materials demand during the forecast period. The consumption of bioactive materials in China holds a valuation of US$ 399.6 million in 2023.

Category-wise Insights

Which Bioactive Material Contributes the Most to Revenue?

In order to prevent secondary caries, bioactive composites are especially employed in dental restorations. Due to the presence of active components, bioactive composite's caries-preventive action which is achieved by remineralizing hard dental tissues and engaging in antimicrobial activity. The major benefit of using bioactive composite material in dental procedures is it replenishes the tissue by providing calcium, phosphate, and other ions.

Additionally, it reduces postoperative sensitivity, and dentin hypersensitivity, inhibits bacterial growth, and improves the durability of bonding between the composite material and dentin.

Bioactive composites based on bioactive glasses are the most suitable for dental applications. Bioactive glasses are mainly composed of silicon oxide, calcium oxide, phosphorus pentoxide, and others that exhibit antibacterial effects due to a rise in pH. These composite minerals have a remineralizing effect by releasing calcium & phosphate ions into the dental tissue

Almost 40% of all consumption in 2022 came from the market for bioactive composite materials.

Hence, the usage of bioactive composite materials in regenerative and reconstructive tissue development is expected to increase the demand. The market for bioactive composite material is expected to grow at a CAGR of 15.2% by the end of the forecast period.

Why Do Biomedical Applications Prefer Powdered Bioactive Materials?

In 2022, sales of powdered bioactive materials accounted for about 38.2% of the total bioactive material market. For biomedical applications including tissues, scaffolds, and fixation tools, specific fabrication is necessary.

Hence, imprinted powders rather than solid support structures should be used to support intricate components during printing. The market valuation of powered bioactive material in 2023 is US$ 1.1 billion and is expected to increase at a CAGR of 12.8% by the end of the forecast period.

Key Strategies Followed by Key Manufacturers

Prominent bioactive materials manufacturers are Zimmer Holding Inc., Medtronic Inc., Stryker Corporation, Pulpdent Corporation, Noraker, Septodont Holding, C.I. TAKIRON Corporation, and Lineage Cell Therapeutics.

To meet the rising demand, key manufacturers are focusing on improving product efficiency. In addition, the manufacturers are employing both organic and inorganic growth strategies in an effort to establish a commanding position in the market.

For Instance :

The distribution rights for Celularity's placenta-derived biomaterial products for orthopedics and sports medicine are transferred to Arthrex under a distribution deal by the latter and Arthrex in July 2021.

Fact.MR has provided detailed information about the price points of key manufacturers of bioactive materials positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Bioactive Materials Industry Research

• By Material :

  • Glass Material
  • Glass Ceramic
  • Composite Material
  • Other Bioactive Materials

• By Type :

  • Powdered
  • Mouldable
  • Granulated
  • Injectable

• By Application :

  • Dentistry
  • Surgery
  • Bioengineering
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA